Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2296-2299

  Herbert, Daniel ^a   Paramasivan, C N ^a   Venkatesan, P ^a   Kubendiran, G ^a   Prabhakar, R ^a   Mitchison, D A ^b  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; OFLOXACIN; RIFAMPICIN; SULTAMICILLIN;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0029819235     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2296     Document Type: Article

References (21)

1. Bush, K. 1988. Beta-lactamase inhibitors from laboratory to clinic. Clin. Microbiol. Rev. 1:109-123.
2. DeMaio, J., Y. Zhang, C. Ko, D. G. Young, and W. R. Bishai. 1996. A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 93:2790-2794.
3. Dickinson, J. M., and D. A. Mitchison. 1981. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 123:367-371.
4. Dickinson, J. M., and D. A. Mitchison. 1990. In vitro activities against mycobacteria of two long acting rifamycins, FCE 22807 and CGP 40/469A (SPA-S-565). Tubercle 71:109-115.
5. Foulds, G. 1986. Pharmacokinetics of sulbactam/ampicillin in humans: a review. Rev. Infect. Dis. 8(Suppl. 5):S503-S511.
6. Heifets, L. B., and P. J. Lindholm-Levy. 1987. Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Tubercle 68:267-276.
7. Hobby, G. L., and T. F. Lenert. 1957. The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells. Am. Rev. Tuberc. PuIm. Dis. 6:1031-1048.
8. Hong Kong Chest Service/British Medical Research Council. 1992. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tubercle Lung Dis. 73:59-67.
9. Jindani, A., V. R. Aber, E. A. Edwards, and D. A. Mitchison. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121:939-949.
10. Lalande, V., C. Truffot-Pernot, A. P. Moulin, J. Grosset, and B. Ji. 1993. Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice. Antimicrob. Agents Chemother. 37:407-413.
11. Mitchison, D. A. 1985. The action of antituberculosis drugs in short course chemotherapy. Tubercle 66:219-225.
12. Mitchison, D. A. 1992. The Garrod lecture. Understanding the chemotherapy of tuberculosis - current problems. J. Antimicrob. Chemother. 29:477-493.
13. Mitchison, D. A. 1993. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am. Rev. Respir. Dis. 147: 1062-1063.
14. Nadler, J. P., J. Berger, J. A. Nord, R. Cotsky, and M. Saxena. 1991. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest 99:1025-1026.
15. Prabhakaran, K., E. B. Harris, B. Randhawa, and R. C. Hastings. 1992. Reversal of drug resistance in Mycobacterium leprae by ampicillin/sulbactam. Microbios 72:137-142.
16. Ripa, S., L. Ferrante, and M. Prenna. 1990. Pharmacokinetics of sulbactam/ ampicillin in humans after intravenous and intramuscular injection. Chemotherapy (Basel) 36:185-192.
17. Sorg, T. B., and M. H. Cynamon. 1987. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis. J. Antimicrob. Chemother. 19:59-64.
18. Tsukamura, M. 1985. In vitro antituberculosis activity of a new antibacterial substance. Ofloxacin (DL 8280). Am. Rev. Respir. Dis. 131:348-351.
19. Tsukamura, M. 1985. Antituberculosis activity of ofloxacin (DL 8280) on experimental tuberculosis in mice. Am. Rev. Respir. Dis. 135:915.
20. Venkataraman, P., C. N. Paramasivan, and R. Prabhakar. 1994. In vitro activity of ciprofloxacin and ofloxacin against South Indian isolates of Mycobacterium tuberculosis. Indian J. Tuberc. 41:87-90.
21. Wayne, L. G. 1994. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13:908-914.